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Abstract: This study investigated the combined application
of Transforming Growth Factor b-1 (TGFb-1) and Bone Mor-
phogenetic Protein-2 (BMP-2) to stimulate osteogenic expres-
sion in vitro. TGFb-1 and BMP-2 fulfill specific roles in the
formation of new bone. COLLOSS1 E, a bone-derived colla-
gen product containing a variety of naturally occurring
growth factors, was also used. Growth factors were adminis-
tered to osteoblast-like cells from rat bone marrow (RBM).
Proliferation and differentiation were monitored up to 24
days, by measuring total DNA content, alkaline phosphatase
activity, and calcium content. Genetic expression of a set of
differentiation markers at day 7 was measured by Q-PCR.
Adding BMP-2 alone induced high proliferation rates, com-
pared to the growth factor supplemented groups, and it
induced high differentiation rates, compared to the control
group. Adding TGFb-1 combined with BMP-2, TGFb-1
alone, or COLLOSS1 E resulted in a significant decrease in
proliferation rate, but an increase in differentiation rate, com-
pared to the control group. Additive or synergistic effects of
application of TGFb-1 and BMP-2 were not observed. The
observed effects of COLLOSS1 E mainly resembled those of
TGFb-1 application alone. It can be concluded that BMP-2 is
the most suitable candidate for osteogenic stimulation
of RBM cells in these settings.  2007 Wiley Periodicals, Inc.
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INTRODUCTION
For the regeneration of large bone defects resulting
from trauma, pathology, or congenital malforma-
tions, synthetic bone substituting materials have
been developed, some of which incorporate one or
more of the biological features of an autologous
bone graft. These features include osteoconductive
and osteoinductive properties, in addition to viable
osteoprogenitor cells.1 Bone tissue engineering tech-
niques can be used to grow osteoprogenitor cells on
synthetic or natural scaffolds,2,3 while growth factors
like the Insulin-like Growth Factors (IGFs) and mem-
bers of the Transforming Growth Factor-b (TGF-b)
superfamily, TGFb-1, TGFb-2, TGFb-3, BMP-1, BMP-
2, and BMP-7 (aka OP-1), are able to grant scaffolds
osteoinductive properties.1
One of the TGF-b superfamily members is TGFb-
1, which is expressed at high levels during bone de-
velopment, growth, and healing. Osteoblasts pro-
duce TGFb-1, which is incorporated into mineralized
bone matrix.1 In vitro, TGFb-1 has been observed to
both inhibit and stimulate osteoblastic cell prolifera-
tion depending on TGFb-1 concentration, cell den-
sity, and the stage of differentiation.1,4,5 In vivo,
TGFb-1 appears to play a decisive role in the early
phase of bone synthesis.6
Bone morphogenetic proteins (BMPs) form a
unique group of proteins within the TGF-b superfam-
ily. BMP-2 promotes differentiation of osteoprogenitor
cells into osteoblasts and matrix formation, thus mak-
ing it a suitable growth factor to use for bone tissue
engineering.4,7–10 The expression of BMP-2 and TGFb-
1 is thought to be regulated by a positive feedback
mechanism of these two growth factors.1
Although recombinant growth factors are potent,
the high expense poses a problem for clinical treat-
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ment. To solve this problem, alternative sources of
growth factors are also examined, for instance, COL-
LOSS1 E. This is a lyophilized complex of extracellu-
lar-matrix proteins extracted from (equine) long bones.
The preparatory methods are similar to those origi-
nally used by Urist and Strates to isolate BMPs.11 The
main constituents of COLLOSS1 E are collagen type I
chains in combination with TGFb-1, BMP-2, BMP-7,
VEGF, IGF-1, TGFb-2, and BMP-3 and several other,
not yet determined, growth factors. COLLOSS1 E is
proven to be osteoinductive in an in vivo situation.12–16
However, the use of COLLOSS1 E as a stimulus for
mesenchymal stem cells for a tissue engineering
approach is not yet described.
The aim of this study was to compare the effects
of different growth factors at various concentrations,
and in different combinations, on rat bone marrow
(RBM) cells in vitro. TGFb-1, BMP-7, and BMP-2 are
commercially available; however, in this study only
TGFb-1 and BMP-2 are used to reduce parameters. It
is hypothesized that TGFb-1 mainly stimulates the
proliferation, and BMP-2 the differentiation of the
cells, whereas together they obtain an additive or
even synergistic effect on cell growth and differentia-
tion. COLLOSS1 E is expected to function likewise
as TGFb-1 combined with BMP-2.
Therefore, in the current study setup RBM cells
were seeded onto 24-well dishes and cultured in me-
dium for 24 days, with added growth factors for the
first 8 days. The effect of the growth factors was
evaluated by DNA content assay, ALP activity assay,
and calcium assay and by scanning electron micros-
copy (SEM) on days 1, 4, 7, 16, and 24. In addition,
on day 7, the effect of the growth factors on mRNA
expression of osteocalcin, collagen type I, alkaline
phosphatase, and bone sialoprotein was evaluated
with quantitative PCR.
MATERIALS AND METHODS
Osteoblast-like cell isolation and culture
RBM cells were isolated and cultured as described by
Maniatopoulos et al.2 Briefly, RBM cells were obtained
from the femora of two 40- to 43-day-old male Wistar WU
rats. The femora were washed three times in alpha Mini-
mal Essential Medium (a-MEM; Gibco BRL, Life Technolo-
gies B.V. Breda, The Netherlands) supplemented with
0.5 mg/mL gentamycin (Gibco) and 3 lg/mL fungizone
(Gibco). Epiphyses were cut off and diaphyses flushed out
with 15 mL culture medium [a-MEM supplemented with
10% fetal calf serum (Gibco), 50 lg/mL gentamycin,
50 lg/mL ascorbic acid (Sigma Chemical Co., St. Louis,
MO)], 10 mM Na-b-glycerophosphate (Sigma), and 1028M
Dexamethasone (Sigma).
To obtain osteoblast-like cells, the RBM suspension was
divided over six culture flasks (75 cm2), and incubated in a
humidified atmosphere of 95% air, 5% CO2 at 378C. The fol-
lowing day, culture medium was refreshed to remove all
nonadherent cells. After 7 days of primary culture, cells were
detached using trypsin/EDTA [0.25% (w/v) trypsin/0.02%
EDTA], resuspended, and seeded at 10,000 cells/cm2 onto
24-well plates (Greiner, Bio-One, Alphen aan den Rijn, The
Netherlands). After 4 h, the culture medium was replaced
with fresh culture medium with added growth factors (Table
I). The concentrations of TGFb-1 and BMP-2 were deter-
mined from previous literature.8,9,17 COLLOSS1 E is known
to contain 38.62 ng/mg TGFb-1 and 4.12 ng/mg BMP-2, as
well as a multiplicity of other growth factors. All samples for
each condition and each time point were present threefold
and the entire experiment was performed twice.
DNA content
After 1, 4, 7, 16, and 24 days of culture, total DNA content
was determined to obtain information about cellular prolifera-
tion, since the DNA content directly correlates to the amount
of the cells. Medium was removed and the cell layer washed
twice with PBS. Subsequent addition of 1 mL MilliQ deion-
ised water to each well and sonication for 10 min lysed the
cells. Samples were stored at 2208C until further use.
For analysis, a PicoGreen dsDNS Quantation Kit (Molec-
ular Probes, Leiden, The Netherlands) was used. A stand-
ard curve was generated using serial dilutions of lambda
DNA ranging from 0 to 2000 ng/mL. Briefly, 100 lL of
sample and 100 lL PicoGreen working solution were
added to a 96-well plate (Greiner). The plate was incu-
bated at room temperature in the dark for 5 min. The plate
was then read at 480–520 nm and the DNA content was
determined with the aid of the standard curve. Samples
and standards were assayed in duplicate.
Alkaline phosphatase activity
The ALP activity was measured after 1, 4, 7, 16, and 24
days, with the same samples as used in the DNA-content
TABLE I
Concentrations and Combinations of Growth Factors
Used in This Experiment in ng/mL (TGFb-1 and BMP-2)
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assay. For the assay, 80 lL of sample and 20 lL of buffer
solution [5 mM MgCl2, 0.5M 2-amino-2methyl-1-propanol
(Sigma)] were added to 96-well plates. Subsequently,
100 lL of substrate solution [5 mM paranitrophenylphos-
phate (Sigma)] was added and the plate was incubated for
1 h at 378C. The reaction was stopped by the addition of
100 lL of 0.3M NaOH and finally, the plate was read at
405 nm. With the aid of a standard curve [4-nitrophenol
(4-NP; Sigma)], serial dilutions ranging from 0 to 25 nM,
the ALP activity was determined in nmol 4-NP produced
per hour per nanogram DNA. Samples and standards
were assayed in duplicate.
Calcium
To obtain information about mineralized matrix forma-
tion, the calcium (Ca) content was determined after 7, 16,
and 24 days of culturing. The samples originated from the
same 24-well plates as used for the DNA content and ALP
activity assays. Ca content was determined using the
ortho-cresolphtalein complexone [OCPC (Sigma)] method.
The 24-well plates were rinsed twice with PBS followed by
the addition of 500 lL acetic acid (0.5N) and overnight
incubation at room temperature. Samples were frozen at
2208C until further use.
OCPC solution was prepared by the addition of 80 mg
of OCPC to 75 mL of demineralized H2O with 0.5 mL
KOH (1M) and 0.5 mL acetic acid (0.5N). To prepare the
sample solution, 5 mL of OCPC solution was added to 5
mL 14.8M ethanolamine–boric acid buffer (pH 11), 2 mL of
8-hydroxyquinoline (5 g in 100 mL 95% ethanol), and
88 mL of demineralized water. Three-hundred microliters
of this sample solution was added to 10 lL of sample. The
plate was incubated at room temperature for 10 min and
read at 575 nm using a microplate reader. A standard
curve was made from serial dilutions of CaCl2, ranging
from 1–200 lg/mL. Samples and standards were assayed
in duplicate.
Realtime-PCR
First, RNA was isolated from the cells after 7 days of
culture (six wells were pooled), with the RNeasy isolation
kit (Qiagen Benelux B.V., Venlo, The Netherlands). Subse-
quently, a reverse transcriptase (RT) reaction was per-
formed by supplementing 1 lg of total RNA, 1 lL (50–250
ng) of random primers, and 1 lL dNTP mix (10 mM each)
in a total volume of 15 lL RNase-free water. The mixture
was heated to 658C for 5 min and quickly chilled on ice.
The contents of the tube were collected by brief centrifuga-
tion and 4 lL 53 First Strand Buffer (250 mM Tris-Cl, pH
8.3, 375 mM KCl, 15 mM MgCl2) and 2 lL 0.1M DDT were
added. This mixture was incubated for 10 min at 258C, fol-
lowed by the addition of 1 lL (200 units) of SUPERSCRIPT
II and incubation for 50 min at 428C. The reaction was
inactivated by heating the mixture at 708C for 15 min. The
cDNA was used as a template in the real-time polymerase
chain reaction (Q-PCR).
iQ SYBR Green Supermix [12.5 lL; 23 mix contains 100
mM KCl, 40 mM Tris-HCl, pH 8.4, 0.4 mM each dNTP
(dATP, dCTP, dGTP, dTTP), 50 U/mL iTaq DNA polymer-
ase, 6 mM MgCl2, SYBR Green I, 20 nM fluorescein, and
stabilizers; BioRad, Hemel Hempstead, UK], 1.5 lL for-
ward amplification primer (10 lM; see Table II), 1.5 lL
reverse amplification primer (10 lM; see Table II), 2 lL
cDNA, and 7.5 lL RNase-free water were added to a PCR
reaction plate to a final volume of 25 lL per sample. The
contents of the plate were mixed gently and collected by
brief centrifugation.
The plate was placed in the Q-PCR MyiQ Single-color
Real Time detection system and the reaction started after a
heat reaction of 948C for 3 min. The measurements were
performed by the following calculations, with GAPDH
serving as a control:
1. DCT 5 CT,gene of interest 2 CT,GAPDH
2. DDCT 5 DCT,sample 2 DCT,control
3. 22DDCT
Scanning electron microscopy
Samples were taken after 1, 4, 7, 16, and 24 days, and
washed three times with PBS. Fixation of the cells was car-
ried out for 5 min in 2% glutaraldehyde. Then, the sub-
strates were washed for 5 min with 0.1M sodium–cacodyl-
ate buffer (pH 7.4), dehydrated in a graded series of etha-
nol, and dried with tetramethylsilane. The substrates were
sputter-coated with gold and examined using a Jeol 6310
SEM.
Statistical analysis
The complete experiment was performed twice. Every
sample was present threefold and measured in duplicate.
Statistical analysis was performed using an ANOVA with
TABLE II
Amplification Primers Used for the Q-PCR of Osteoblast-Like Cells
Amplification Primer 1 (Forward) Amplification Primer 2 (Reverse)
Osteocalcin (OC) GGCTTCCAGGACGCCTACA CATGCCCTAAACGGTGGTG
Collagen type I (Col I) TGGAATCTTGGATGGTTTGGA GCTGTAAACGTGGAAGCAAGG
Alkaline phosphatase (ALP) GCTTCACGGCATCCATGAG GAGGCATACGCCATGACGT
Bone sialoprotein (BSP) ACTTCCCTTCGCAAGCTTAGG AAACTTCCCGCGTATGTTGG
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) GCCTAAATGATACCCCACCGT GCTGGCACTGCACAAGAAGA
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post-hoc Tukey test. Calculations were performed in InStat
software (v 3.05 Graphpad).
RESULTS
In general, the results of all assays were largely
comparable between both the individual experi-
ments. All depicted results are derived from the sec-
ond experiment.
DNA content
The results from the DNA assay are shown in Fig-
ure 1. The control group gave a significant increase in
DNA content until day 16. After day 16, a decrease in
DNA content was observed. A similar growth pattern
like that of the control group was seen for all other
groups. However, the combined TGFb-1/BMP-2, and
the 2.5 lg/mL COLLOSS1 E groups reached maxi-
mum values at earlier time points. Following the con-
trol group, the highest DNA content was observed for
the BMP-2 group. The TGFb-1 combined with BMP-2
groups gave the lowest contents. The DNA content of
the COLLOSS1 E and the TGFb-1 groups was just
above the TGFb-1 combined with BMP-2 groups and
peaked around day 16. At day 16 a significant differ-
ence was observed between the control and BMP-2
group and the other groups.
Alkaline phosphatase activity
Results of the ALP activity measurement are
depicted in Figure 2. The control group showed a
significant increase in activity with time, with the
highest measurements between days 7 and 16. On
days 7 and 16, a significant upregulation of ALP ac-
tivity, with a maximum around day 16, was
observed for the TGFb-1 combined with BMP-2
groups when compared to the control group. The
ALP activities of the TGFb-1 and COLLOSS1 E
groups lay below those of the TGFb-1 combined
with BMP-2 groups; the upregulation of TGFb-1 was
significant on days 7 and 16 compared to the control
group. They reached their maxima around day 16. A
maximum peak in ALP activity was seen early for
the BMP-2 group at day 7 and at that time point, the
ALP activity was significantly upregulated when
compared with the control group.
Calcium
Results from the Ca measurement are depicted in
Figure 3. No calcium content was detectable before
Figure 1. Cell proliferation curve by a total DNA mea-
surement; results are in ng/mL.
Figure 2. ALP activity measurement results. The ALP
activity was determined in nmol 4-NP produced per hour
per nanogram DNA (nmol/h/lg). ALP is an early differ-
entiation marker and correlates to the differentiation of the
cells.
Figure 3. Concentration of calcium in lg/mL. Calcium is
a late differentiation marker and correlates to the late dif-
ferentiation of the cells.
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day 16. On day 16, the content started to increase
significantly upto day 24 for the control group. The
measurements of the BMP-2 group seemed to
increase at an earlier time point. The TGFb-1 group
showed no mineralization at day 16 and a signifi-
cantly lower value at day 24, compared to the con-
trol group. The calcium content of the TGFb-1 com-
bined with BMP-2 and the COLLOSS1 E groups
were between the control and TGFb-1 group, with
little mineralization for the TGFb-1 combined with
BMP-2 groups and no mineralization for the COL-
LOSS1 E groups at day 16. On day 24 the calcium
content of the control and BMP-2 group are similar,
and seems to be lower in the other groups. How-
ever, this difference is not significant except for the
TGFb-1 group.
Realtime-PCR
The quantative PCR results are depicted in Table
III. The TGFb-1 group showed an increase in mRNA
for Col I, whereas all other differentiation markers
(ALP, OC, and BSP) were down-regulated. The
BMP-2 group gave exactly opposite results; all differ-
entiation markers were upregulated, however, Col I
could not be detected. The TGFb-1 þ BMP-2 group
showed a small decrease in OC and an increase in
BSP and especially in ALP. The TGFb-1, followed by
BMP-2 group, also showed a small decrease in OC
and high increases in ALP and especially BSP. The
COLLOSS1 E groups in general showed a down-
regulation of all differentiation markers, and mostly
resembled the TGFb-1 group.
Scanning electron microscopy
Representative scanning electron micrographs are
depicted in Figure 4(A,B) (control samples, days 4
and 24), Figure 5(A,B) (BMP-2 samples, days 4 and
24), and Figure 6(A,B) (COLLOSS1 E, 10.0 lg/mL
samples, days 4 and 24). The control group showed
a pattern of cell growth and differentiation starting
with cell attachment, spreading, and proliferation at
days 1–4, matrix formation around days 7–16, and
calcification of the matrix after day 16, which was
expected. This pattern of growth and differentiation
was also observed for all the other groups. However,
the TGFb-1 combined with BMP-2 groups started to
calcify the matrix before day 16 and as a general
remark, it could be said that the BMP-2 group dis-
played a confluent monolayer and an even distribu-
tion of matrix like the control group, whereas all
other groups showed patches of cells with matrix
formation and calcification.
DISCUSSION
Expansion of knowledge concerning growth fac-
tors is a necessity when preparing osteoinductive
TABLE III
Q-PCR Results (in Percentages)
OC (%) Col I (%) ALP (%) BSP (%)
TGFb-1 49 181 51.80 46
BMP-2 167.00 NA 125.70 343.40
TGFb-1 followed
by BMP-2 78.50 NA 254.90 783.50
TGFb-1 þ BMP-2 76.80 111 459.50 135.70
COLLOSS1 E,
2.5 lg/ml 22.50 NA 99.30 85.30
COLLOSS1 E,
5.0 lg/ml 17.10 NA 44.40 32.50
COLLOSS1 E,
10.0 lg/ml 8.20 85 77.40 41.80
Samples are compared to the control sample and cor-
rected for the household gene—Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH).
Figure 4. A, B: Scanning electron micrographs of the con-
trol samples at days 4 (A) and 24 (B) at 3250 magnifica-
tion. The control samples show cell attachment and
spreading on day 4 and calcification of the extracellular
matrix at day 24.
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scaffolds. In the current investigation, a number of
relevant growth factors were examined individually
and in combinations. The focus of this project was
on the effects of the growth factors on proliferation
and differentiation of osteoblast-like cells. Good pro-
liferation and differentiation rates were seen after
BMP-2 application and increased differentiation rates
were observed for the TGFb-1 combined with BMP-2
groups.
Regarding our study setup, some variance in pro-
liferation and differentiation onset of the cells,
between the first and the second experiment was
observed. However, although the differentiation of
the cells, matrix formation, and calcification started
somewhat later in the first experiment, the growth
and differentiation curve between all groups corre-
sponded in both experiments. Since data were repro-
ducible, valid conclusions can be made. The phe-
nomenon of differing growth and differentiation
rates between experiments is due to the use of pri-
mary cells; earlier studies already reported about the
use of these primary cell lines, which did not pro-
duce the exact same results.9,18 Another technical
remark has to be made on the addition of the
growth factors. All growth factors except BMP-2,
had a marked effect on the morphology of the cell
layer, in comparison to the control group. The cell
layer was always less confluent and cells appeared
more rounded. This effect was most markedly visi-
ble in the COLLOSS1 E groups. COLLOSS1 E con-
tains high concentrations of TGFb-1, compared to
the other growth factors present in COLLOSS1 E,
which is known to influence the morphology and
attachment of bone-like cells. Possibly, this effect is
even enhanced by other, yet undetermined growth
factors present in COLLOSS1 E.
The decrease in DNA content, that is seen in all
groups after day 16, happens when these cells are
cultured for a period longer than 16 days.19 The rea-
son for this lies in the fact that the cells have differ-
Figure 6. A, B: Scanning electron micrographs of the
COLLOSS1 E 10.0 lg/mL samples at days 4 (A) and 24
(B) at 3250 magnification. This group showed a cell
attachment and spreading on day 4 and calcification of the
extracellular matrix at day 24, as also seen for the control
samples [Fig. 4(A,B)].
Figure 5. A, B: Scanning electron micrographs of the
BMP-2 samples at days 4 (A) and 24 (B) at 3250 magnifi-
cation. Note, the extensive cell attachment and spreading
on day 4 as well as the calcification of the extracellular ma-
trix at day 24, as also seen for the control samples [Fig.
4(A,B)].
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entiated by this time point and therefore do not pro-
liferate anymore, combined with a lower efficiency
of DNA extraction, because of embedding of the
cells in the extracellular matrix.
Earlier studies suggest that BMP-2 especially stim-
ulates the differentiation of osteoblast-like cells.7–9
This theory is supported by the early significant
upregulation of ALP activity and the upregulation of
differentiation markers in the quantitative-PCR at
day 7 and the high calcium content that was found
at day 24. Also, the initial cell seeding density can
significantly influence the final behavior of the cell
cultures. For instance, in the study of van den
Dolder et al., 20,000 cells/cm2 were used, which is
twice as high as the concentration used in this study.
The effects of growth factors are always related to
the number and differentiation stage of the cells.
The proliferation results of the cells stimulated
with BMP-2 were significantly higher than those of
the other groups that received growth factors, how-
ever they were always lower than the control group.
A possible explanation for this phenomenon is the
stimulation of differentiation of the cells by BMP-2,
which causes an earlier start of differentiation of the
cells that would otherwise proliferate for a longer
time period.
In contrast to BMP-2, literature is more divided
about the effect of TGFb-1 on osteoblast-like cells.
Some investigations show that TGFb-1 stimulates
cell proliferation and inhibits differentiation,20,21
whereas in other articles exactly the opposite is
reported.17,22,23 These contradictory findings can also
be due to differences in cell concentration and ori-
gin.9 In our study, differentiation was stimulated by
the addition of TGFb-1, whereas proliferation was
decreased.
Many growth factors play a role during the bone
healing process. However, the interaction between
these growth factors is not completely understood
and not much information is available about the
combined effect of growth factors in vitro. This was
the reason that in our study also, combinations of
growth factors were examined. The addition of
TGFb-1 and BMP-2 at the same time or followed by
each other was supposed to induce synergistic
effects on matrix formation and calcification.
Although the ALP-activity measurements as well as
the quantative PCR measurements of ALP and BSP
indicated an increased cell differentiation, the com-
plimentary use of two factors did finally not result
in a confluent layer with a high degree of calcifica-
tion. This can be due to the low proliferation of the
cells during the initial incubation phase.
Interestingly, almost no differences were found
between the COLLOSS1 E groups. Apparently, all
used concentrations are in the same order of magni-
tude and therefore exhibit similar effects.
The effect of COLLOSS1 E was hypothesized to
correspond to the effect of TGFb-1 combined with
BMP-2, since COLLOSS1 E contains both growth
factors, although, some differences can be expected,
since the growth factors in COLLOSS1 E are bound
to collagen. The concentrations of TGFb-1 and BMP-
2 present in COLLOSS1 E are also lower than those
of the TGFb-1 and BMP-2 groups in this study, how-
ever, multiple other factors present in COLLOSS1 E
could possibly compensate for these differences in
concentration.24 In contrast to our initial suggestion,
cell proliferation was higher, and differentiation
lower than seen in the TGFb-1 combined with BMP-
2 group. Evidently, this is due to a large difference
in concentration balance between growth factors in
the COLLOSS1 E material, as recently it has been
shown that 38.62 6 13.57 ng/mg TGFb-1 and 4.12 6
1.32 ng/mg BMP-2 is present in COLLOSS1 E.
Apparently, the high concentration of TGFb-1 over-
rules the effect of BMP-2. The differences, as found
between the TGFb-1 combined with BMP-2 and the
COLLOSS1 E groups, can even be enhanced because
numerous other growth factors like VEGF, IGF-1,
TGFb-2, BMP-7, and BMP-3 are present in COL-
LOSS1 E. Direct or indirect effects of these growth
factors on the behavior of osteoblasts are proven in
earlier studies. The direct effect of VEGF, IGF-1, or
TGFb-2 on the proliferation of osteoprogenitor cells
is unknown, but a direct positive effect on the differ-
entiation of osteogenic cells was confirmed for
VEGF, TGFb-2,25,26 and IGF-1.1,27 BMP-7 promotes
proliferation as well as differentiation of osteoblastic
cells and stimulates bone apposition in certain
in vivo situations.28,29 Although all these growth fac-
tors have a stimulatory effect on bone formation,
BMP-3 has an inhibitory effect on other BMPs. BMP-
3 is a receptor antagonist that competes for common
signaling pathway components in the BMP signaling
pathway, thereby inhibiting bone formation.30,31
Therefore, differentiation of the RBM cells can be
very well inhibited by BMP-3.
In summary, the aim of the current study was to
examine the effects of different potential cell and
bone-like matrix stimulating growth factors on osteo-
blast-like cells. Increased proliferation, compared to
the groups that received growth factors, and differ-
entiation rates were seen for cell cultures supple-
mented with BMP-2. The addition of TGFb-1 com-
bined with BMP-2, TGFb-1, and all COLLOSS1 E to
the cell culture medium resulted in a decrease in
proliferation rate and an increase in differentiation
rate. On basis of these findings, it can be concluded
that, in agreement with our initial hypothesis, BMP-
2 is the most suitable candidate of these (combina-
tions of) growth factors for the early osteogenic stim-
ulation of RBM cells in the used experimental set-
tings. In disagreement with our initial hypothesis,
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additive or synergistic effects of mutual or succes-
sive application of TGFb-1 and BMP-2 were not
observed in this cell culture model and COLLOSS1
E did not show effects resembling those of combined
TGFb-1 and BMP-2. COLLOSS1 E showed effects
that mostly resembled the addition of TGFb-1, prob-
ably caused by the fact that TGFb-1 is the predomi-
nant growth factor component present in COL-
LOSS1 E, although the potential effects of other
growth factors present in COLLOSS1 E cannot be
excluded.
OSSACUR AG provided COLLOSS1 E. Scanning elec-
tron microscopy was performed at the Microscopic Imag-
ing Centre (MIC) of the Nijmegen Centre for Molecular
Life Sciences (NCMLS), the Netherlands.
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